Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.31)
# 3,596
Out of 4,969 analysts
473
Total ratings
34.32%
Success rate
-11.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics | Reiterates: Buy | $34 | $2.83 | +1,101.41% | 4 | Aug 26, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $16 → $14 | $4.11 | +240.63% | 22 | Aug 26, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $41 → $40 | $12.00 | +233.33% | 5 | Aug 22, 2025 | |
| CGEM Cullinan Therapeutics | Assumes: Buy | $24 | $7.72 | +210.88% | 1 | Aug 21, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $138 → $136 | $100.42 | +35.43% | 44 | Aug 14, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $22 → $19 | $10.61 | +79.08% | 25 | Aug 14, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $42 | $19.26 | +118.07% | 11 | Aug 12, 2025 | |
| EXEL Exelixis | Maintains: Buy | $53 → $46 | $36.96 | +24.46% | 10 | Aug 12, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $12 → $10 | $2.88 | +247.22% | 14 | Aug 11, 2025 | |
| YMAB Y-mAbs Therapeutics | Downgrades: Neutral | $11 → $8.6 | $8.57 | +0.35% | 22 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $13.08 | +60.55% | 13 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $1.96 | +410.20% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $0.73 | +447.95% | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.90 | - | 18 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.36 | +25.48% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.08 | - | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $9.46 | +259.41% | 16 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $13 | $14.14 | -8.06% | 21 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $9.36 | +145.73% | 1 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $21.05 | +128.03% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.22 | +215.32% | 8 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.60 | +361.54% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $39.77 | +81.04% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.22 | +309.84% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.89 | +58.73% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $6.70 | +94.03% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.29 | +143.16% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.38 | +195.86% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.91 | +4.71% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.55 | +222.58% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.12 | +614.29% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.15 | +217.46% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.72 | +190.70% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $12.61 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $4.19 | +4,673.27% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.58 | +15,089.87% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.81 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.94 | +15,859.14% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.00 | +600.00% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.12 | +418.87% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $3.04 | +1,480,163.16% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.72 | +572.04% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.44 | +802.78% | 1 | Jan 7, 2021 |
OnKure Therapeutics
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.83
Upside: +1,101.41%
Relay Therapeutics
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $4.11
Upside: +240.63%
Bicara Therapeutics
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $12.00
Upside: +233.33%
Cullinan Therapeutics
Aug 21, 2025
Assumes: Buy
Price Target: $24
Current: $7.72
Upside: +210.88%
BioNTech SE
Aug 14, 2025
Maintains: Buy
Price Target: $138 → $136
Current: $100.42
Upside: +35.43%
ORIC Pharmaceuticals
Aug 14, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $10.61
Upside: +79.08%
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $19.26
Upside: +118.07%
Exelixis
Aug 12, 2025
Maintains: Buy
Price Target: $53 → $46
Current: $36.96
Upside: +24.46%
Black Diamond Therapeutics
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.88
Upside: +247.22%
Y-mAbs Therapeutics
Aug 6, 2025
Downgrades: Neutral
Price Target: $11 → $8.6
Current: $8.57
Upside: +0.35%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $21
Current: $13.08
Upside: +60.55%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $1.96
Upside: +410.20%
Jul 23, 2025
Assumes: Buy
Price Target: $4
Current: $0.73
Upside: +447.95%
Jul 23, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.90
Upside: -
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $10.36
Upside: +25.48%
Jul 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.08
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $9.46
Upside: +259.41%
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $14.14
Upside: -8.06%
Jul 3, 2025
Initiates: Buy
Price Target: $23
Current: $9.36
Upside: +145.73%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $21.05
Upside: +128.03%
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.22
Upside: +215.32%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.60
Upside: +361.54%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $39.77
Upside: +81.04%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.89
Upside: +58.73%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $6.70
Upside: +94.03%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $3.29
Upside: +143.16%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $3.38
Upside: +195.86%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.91
Upside: +4.71%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.55
Upside: +222.58%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.12
Upside: +614.29%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.15
Upside: +217.46%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.72
Upside: +190.70%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $12.61
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $4.19
Upside: +4,673.27%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.58
Upside: +15,089.87%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.81
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.94
Upside: +15,859.14%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.00
Upside: +600.00%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.12
Upside: +418.87%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $3.04
Upside: +1,480,163.16%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.72
Upside: +572.04%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.44
Upside: +802.78%